Association between SOST and/or anti-SOST antibodies with the clinical characteristics of all patient cohorts affected by IBD, with or without articular inflammation.
| Variables | r, n = 94 | 95% CI |
|---|---|---|
| SOST and anti-SOST | −0.47 | −0.65 to −0.27 |
| SOST and IBD duration | −0.02 | −0.28 to 0.21 |
| anti-SOST and IBD duration | −0.01 | −0.25 to 0.24 |